Literature DB >> 22100375

Aortic stenosis and vascular calcifications in alkaptonuria.

Hwaida Hannoush1, Wendy J Introne, Marcus Y Chen, Sook-Jin Lee, Kevin O'Brien, Pim Suwannarat, Michael A Kayser, William A Gahl, Vandana Sachdev.   

Abstract

Alkaptonuria is a rare metabolic disorder of tyrosine catabolism in which homogentisic acid (HGA) accumulates and is deposited throughout the spine, large joints, cardiovascular system, and various tissues throughout the body. In the cardiovascular system, pigment deposition has been described in the heart valves, endocardium, pericardium, aortic intima and coronary arteries. The prevalence of cardiovascular disease in patients with alkaptonuria varies in previous reports. We present a series of 76 consecutive adult patients with alkaptonuria who underwent transthoracic echocardiography between 2000 and 2009. A subgroup of 40 patients enrolled in a treatment study underwent non-contrast CT scans and these were assessed for vascular calcifications. Six of the 76 patients had aortic valve replacement. In the remaining 70 patients, 12 patients had aortic sclerosis and 7 patients had aortic stenosis. Unlike degenerative aortic valve disease, we found no correlation with standard cardiac risk factors. There was a modest association between the severity of aortic valve disease and joint involvement, however, we saw no correlation with urine HGA levels. Vascular calcifications were seen in the coronaries, cardiac valves, aortic root, descending aorta and iliac arteries. These findings suggest an important role for echocardiographic screening of alkaptonuria patients to detect valvular heart disease and cardiac CT to detect coronary artery calcifications. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100375      PMCID: PMC3276068          DOI: 10.1016/j.ymgme.2011.10.017

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  23 in total

1.  Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ronit Katz; Nathan D Wong; Richard Kronmal; Junichiro Takasu; David M Shavelle; Jeffrey L Probstfield; Alain G Bertoni; Matthew J Budoff; Kevin D O'Brien
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  The nature of the defect in tyrosine metabolism in alcaptonuria.

Authors:  B N LA DU; V G ZANNONI; L LASTER; J E SEEGMILLER
Journal:  J Biol Chem       Date:  1958-01       Impact factor: 5.157

3.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

4.  Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Robyn L McClelland; Hyoju Chung; Robert Detrano; Wendy Post; Richard A Kronmal
Journal:  Circulation       Date:  2005-12-19       Impact factor: 29.690

5.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

6.  Aortic stenosis in cardiovascular ochronosis.

Authors:  L V Ffolkes; D Brull; S Krywawych; M Hayward; S E Hughes
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

7.  Ochronosis of the aortic valve and aorta.

Authors:  Miljenko Kovacevic; Ognjen Simic; Igor Medved; Ksenija Lucin; Marijan Padovan
Journal:  J Heart Valve Dis       Date:  2006-09

8.  Use of nitisinone in patients with alkaptonuria.

Authors:  Pim Suwannarat; Kevin O'Brien; Monique B Perry; Nancy Sebring; Isa Bernardini; Muriel I Kaiser-Kupfer; Benjamin I Rubin; Ekaterina Tsilou; Lynn H Gerber; William A Gahl
Journal:  Metabolism       Date:  2005-06       Impact factor: 8.694

9.  Ochronosis and aortic valve stenosis.

Authors:  Jagdish W Butany; Ather Naseemuddin; Yaron Moshkowitz; Vidhya Nair
Journal:  J Card Surg       Date:  2006 Mar-Apr       Impact factor: 1.620

10.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

View more
  6 in total

1.  Narrowing of the dark valve: aortic stenosis in alkaptonuria.

Authors:  Ketak Nagare; Mohammed Idhrees; Mohammed Ibrahim; Aju Jacob; Bashi Velayudhan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-10-02

2.  Ochronotic arthritis and ochronotic Achilles tendon rupture in alkaptonuria: A 6 years follow-up case report in China.

Authors:  Lifeng Jiang; Le Cao; Jinghua Fang; Xinning Yu; Xuesong Dai; Xudong Miao
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.

Authors:  Juliette H Hughes; Ke Liu; Antonius Plagge; Peter J M Wilson; Hazel Sutherland; Brendan P Norman; Andrew T Hughes; Craig M Keenan; Anna M Milan; Takao Sakai; Lakshminarayan R Ranganath; James A Gallagher; George Bou-Gharios
Journal:  Hum Mol Genet       Date:  2019-12-01       Impact factor: 6.150

Review 4.  Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease.

Authors:  Carlos R Ferreira; Nenad Blau
Journal:  Mol Genet Metab       Date:  2020-12-25       Impact factor: 4.797

5.  A patient survey on the impact of alkaptonuria symptoms as perceived by the patients and their experiences of receiving diagnosis and care.

Authors:  Mattias Rudebeck; Ciarán Scott; Nicolas Sireau; Lakshminarayan Ranganath
Journal:  JIMD Rep       Date:  2020-03-07

6.  [Anesthetic management of two patients with alkaptonuric ochronosis for total knee arthroplasty].

Authors:  Betul Kozanhan
Journal:  Braz J Anesthesiol       Date:  2017-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.